Reports and Briefs on Therapy Area in Australia

Published within

« | 1 | » »|

Type Product title / description Pub Price
Report
Report

Commercial Insight: Asthma/COPD in Australia

In-depth overview and 10 year outlook for currently marketed and pipeline asthma/COPD products in Australia, examining both clinical and commercial factors driving product differentiation and uptake.

Published By Datamonitor
20 May 2010 $5700
Buy

Order this report by the 10th September 2010 and receive a 15% discount

To take advantage of this offer enter Promo Code opioid15 when prompted in the checkout

More information

Report
Report

Commercial Insight: Opioids in Australia

In-depth overview and 10 year outlook for currently marketed and pipeline opioid products in Australia, examining both clinical and commercial factors driving product differentiation and uptake.

Published By Datamonitor
20 May 2010 $5700
Buy
Report
Report

Epidemiology: Diabetes in Australia - Despite government efforts to promote healthy lifestyles, the number of cases of diabetes in Australia is set to soar

Overview of diabetes definition and review of epidemiology literature. This report provides in-depth analysis of patient populations, a 10-year incidence and prevalence case forecast, and key patient segments across Australia.

Published By Datamonitor
17 Jun 2011 $2800
Buy
Report
Report

Hot Topics in Diabetes: the future of antidiabetics in Australia

This report provides an update on the state of diabetes management in Australia, an overview of insulin and non-insulin antidiabetics currently marketed in Australia, and prospects for pipeline compounds in development for the treatment of diabetes.

Published By Datamonitor
29 Sep 2011 $2800
Buy
Report
Report

Pharmaceutical M&A in the Asia-Pacific Region - India and China drive regional activity but Japan still dominates high value transactions

An overview of merger and acquisition (M&A) trends in developed and emerging pharmaceutical markets in the Asia-Pacific region from Q1 2007 to Q1 2010, with discussion of the drivers of recent deals and analysis of key M&As in individual countries.

Published By Datamonitor
19 Aug 2010 $7600
Buy

« | 1 | » »|

No help is available.